Cyproterone acetate and ethinylestradiol are synthetic hormones used together in combined hormone therapy. The medication acts as an antiandrogen by binding to androgen receptors and blocking the effects of male sex hormones. At the same time it provides a progestogenic component that stabilizes the endometrium and contributes to contraceptive efficacy. Ethinylestradiol supplies estrogen activity that suppresses ovulation through inhibition of the hypothalamic-pituitary-gonadal axis. Together they modulate hormone-dependent processes such as acne, hirsutism, and menstrual regulation. The combined action reduces androgen-driven skin changes while maintaining cycle control through sustained estrogenic stimulation.

Cyproterone acetate and ethinylestradiol are combined hormonal agents used in specific therapeutic contexts. The combination functions as an antiandrogen and estrogenic component providing a dual hormonal modulation. Cyproterone acetate blocks androgen receptors and suppresses luteinizing hormone release reducing testosterone activity. Ethinylestradiol supplies estrogenic stimulation that stabilizes the endometrium and prevents ovulation through feedback inhibition. Together they produce a reversible suppression of gonadal hormone production while maintaining contraceptive efficacy. This pharmacological profile enables the agents to be employed in the management of conditions such as hormone-sensitive cancers and certain dermatologic disorders.

Cyproterone acetate can lead to decreased androgen activity and may cause menstrual irregularities. It is also associated with breast tenderness and occasional mood swings. Ethinylestradiol often produces breakthrough spotting and can alter cycle timing. Some individuals report headaches and mild nausea after starting the combined formulation. Acne may improve or worsen depending on individual response. Weight changes have been noted with both agents but are generally modest. Mood alterations such as irritability or mild depression have been observed in clinical reports.

Cyproterone acetate is a synthetic compound that can affect hormonal balance in the body. One frequent side effect reported is a change in sexual desire which may increase or decrease. Hot flashes and occasional sweating have also been noted in some individuals. Mood alterations such as irritability or mild anxiety can occur occasionally. Ethinylestradiol commonly leads to breast tenderness and spotting between menstrual cycles. Some users experience nausea or mild headaches during the early adjustment period. Weight fluctuations and fluid retention have been observed in a minority of patients. These reactions are generally mild and often diminish as the body adapts to the medication.